Gilead takes legal action against counterfeit HIV drug network
pharmaphorum
JANUARY 20, 2022
US pharma giant Gilead Sciences has accused a network of unauthorised suppliers and distributors of selling more than $250 million of counterfeit versions of its HIV medications. This works to ensure the safety and efficacy of the drugs received by patients.
Let's personalize your content